224 related articles for article (PubMed ID: 35854043)
41. Coincidental crystalline light chain cast nephropathy, light chain proximal tubulopathy, and urine crystallopathy: A case report and review of the literature
.
Lerner G; Moradi S; Cohen-Bucay A; Chen H; Sanchorawala V; Gordon CE; Henderson JM
Clin Nephrol; 2020 Apr; 93(4):203-208. PubMed ID: 31907143
[TBL] [Abstract][Full Text] [Related]
42. Paraprotein-Related Kidney Disease: Evaluation and Treatment of Myeloma Cast Nephropathy.
Finkel KW; Cohen EP; Shirali A; Abudayyeh A;
Clin J Am Soc Nephrol; 2016 Dec; 11(12):2273-2279. PubMed ID: 27526708
[TBL] [Abstract][Full Text] [Related]
43. Lack of Renal Recovery Predicts Poor Survival in Patients of Multiple Myeloma With Renal Impairment.
Sharma R; Jain A; Jandial A; Lad D; Khadwal A; Prakash G; Nada R; Aggarwal R; Ramachandran R; Varma N; Malhotra P
Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):626-634. PubMed ID: 35610119
[TBL] [Abstract][Full Text] [Related]
44. Light chain crystalline kidney disease: diagnostic urine microscopy as the "liquid kidney biopsy".
Luciano RL; Castano E; Fogazzi GB; Perazella MA
Clin Nephrol; 2014 Dec; 82(6):387-91. PubMed ID: 25295579
[TBL] [Abstract][Full Text] [Related]
45. Myeloma Cast Nephropathy and COVID-19: A Case Report of Multiple Myeloma Presenting as Acute Kidney Injury in the Setting of COVID-19.
Memon W; Popli K; Akram A; Bobba S; Muthusamy S
Cureus; 2021 Apr; 13(4):e14461. PubMed ID: 33996321
[TBL] [Abstract][Full Text] [Related]
46. Early use of PEPA dialyzer for light chains removal and for the recovery from myeloma cast nephropathy: A case report.
Donati G; Zappulo F; Croci Chiocchini AL; Comai G; Zamagni E; La Manna G
Hemodial Int; 2019 Jul; 23(3):E97-E99. PubMed ID: 30791209
[TBL] [Abstract][Full Text] [Related]
47. Fabry disease associated with multiple myeloma: a case report.
Adachi K; Tokuyama H; Oshima Y; Itoh T; Hashiguchi A; Yamakawa H; Togawa T; Sakuraba H; Wakino S; Itoh H
CEN Case Rep; 2022 Feb; 11(1):146-153. PubMed ID: 34529243
[TBL] [Abstract][Full Text] [Related]
48. Combined crystal-storing histiocytosis, light chain proximal tubulopathy, and light chain crystalline podocytopathy in a patient with multiple myeloma: a case report and literature review.
Zhu L; Wang L; Shi H; Jiang L; Li X; Shao C; Yan Y; Dong B; Zou W; Zuo L
Ren Fail; 2023 Dec; 45(1):2145970. PubMed ID: 36632756
[TBL] [Abstract][Full Text] [Related]
49. Successful use of combined high cut-off haemodialysis and bortezomib for acute kidney injury associated with myeloma cast nephropathy.
Ward F; Dunne O; Crotty TB; Fennelly D; Watson A; Holian J
Ir Med J; 2012 May; 105(5):148-9. PubMed ID: 22803494
[TBL] [Abstract][Full Text] [Related]
50. Renal recovery following daratumumab, lenalidomide, and dexamethasone therapy in a patient with newly diagnosed dialysis-dependent multiple myeloma.
Mizuno S; Kitayama C; Mashiko S; Sanada S
CEN Case Rep; 2022 May; 11(2):265-268. PubMed ID: 34817845
[TBL] [Abstract][Full Text] [Related]
51. [Withdrawal of maintenance dialysis in a patient with diagnosed multiple myeloma and renal failure as a consequence of effective anti-tumor treatment].
Rosa J; Sydor A; Jurczyszyn A; Zabawa-Hołyś S; Nowak J; Czapkowicz-Gryszkiewicz L; Sułowicz W
Przegl Lek; 2010; 67(7):547-50. PubMed ID: 21387773
[TBL] [Abstract][Full Text] [Related]
52. Renal failure caused by plasma cell infiltration in multiple myeloma.
Hanawa S; Akimoto T; Uehara E; Inoue M; Imai T; Kotoda A; Yoshizawa H; Matsuyama T; Ueda M; Saito O; Hamano Y; Yumura W; Ozawa K; Muto S; Kusano E
Clin Exp Nephrol; 2011 Aug; 15(4):586-90. PubMed ID: 21437577
[TBL] [Abstract][Full Text] [Related]
53. Bence-Jones Protein λ-type Multiple Myeloma Patient Withdrawn from Maintenance Hemodialysis after Long-term Bortezomib and Dexamethasone Therapy.
Yamaguchi W; Yui N; Nagao T; Oshikawa G; Negi M; Iimori S; Okado T; Rai T; Uchida S
Intern Med; 2016; 55(3):263-8. PubMed ID: 26831021
[TBL] [Abstract][Full Text] [Related]
54. Optimizing treatment strategies in myeloma cast nephropathy: rationale for a randomized prospective trial.
Bridoux F; Fermand JP
Adv Chronic Kidney Dis; 2012 Sep; 19(5):333-41. PubMed ID: 22920644
[TBL] [Abstract][Full Text] [Related]
55. Non-crystalline light chain proximal tubulopathy associated with monoclonal gammopathy of renal significance: A case report and review of the literature.
Li F; Xie X; Sun L; Zhang Z; Chen J; Wang X
Clin Nephrol; 2023 Jan; 99(1):32-40. PubMed ID: 36444974
[TBL] [Abstract][Full Text] [Related]
56. Cast nephropathy with acute renal failure treated with high cut-off haemodialysis in a patient with multiple myeloma.
Shum HP; Chan KC; Chow CC; Kho BC; Yan WW
Hong Kong Med J; 2010 Dec; 16(6):489-92. PubMed ID: 21135429
[TBL] [Abstract][Full Text] [Related]
57. Acute kidney injury on chronic kidney disease: from congestive heart failure to light chain deposition disease and cast nephropathy in multiple myeloma.
Shaikh S; Nwankwo C; Lacasse A; Cheng S
J Community Hosp Intern Med Perspect; 2019; 9(4):319-321. PubMed ID: 31531214
[TBL] [Abstract][Full Text] [Related]
58. Combined renal proximal tubulopathy and crystal storing histiocytosis in a patient with κ light chain multiple myeloma.
Ungari M; Ghiringhelli P; Marchi G; Fisogni S; Lavazza A; Molteni A; Malberti F; Bertoni R; Trombatore M; Ferrero G; Gusolfino MD; Varotti E; Tanzi G; Manotti L
Pathologica; 2021 Aug; 113(4):285-293. PubMed ID: 34463673
[TBL] [Abstract][Full Text] [Related]
59. Treatment of acute kidney injury with cast nephropathy.
Walther C; Podoll AS; Finkel KW
Clin Nephrol; 2014 Jul; 82(1):1-6. PubMed ID: 24725380
[TBL] [Abstract][Full Text] [Related]
60. Crystalline cast nephropathy in a patient with IgD lambda myeloma.
Kumakura S; Nakaya I; Sakuma T; Sato H; Soma J
Clin Exp Nephrol; 2016 Jun; 20(3):491-2. PubMed ID: 26515717
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
